Format

Send to

Choose Destination
Essays Biochem. 2018 Jul 20;62(3):399-408. doi: 10.1042/EBC20170110. Print 2018 Jul 20.

Advancing genomic approaches to the molecular diagnosis of mitochondrial disease.

Author information

1
Institute of Human Genetics, Technische Universität München, München 48559, Germany prokisch@helmholtz-muenchen.de.
2
Institute of Human Genetics, Helmholtz Zentrum München, München 85764, Germany.
3
Institute of Human Genetics, Technische Universität München, München 48559, Germany.

Abstract

Mitochondrial diseases present a diagnostic challenge due to their clinical and genetic heterogeneity. Achieving comprehensive molecular diagnosis via a conventional candidate-gene approach is likely, therefore, to be labour- and cost-intensive given the expanding number of mitochondrial disease genes. The advent of whole exome sequencing (WES) and whole genome sequencing (WGS) hold the potential of higher diagnostic yields due to the universality and unbiased nature of the methods. However, these approaches are subject to the escalating challenge of variant interpretation. Thus, integration of functional 'multi-omics' data, such as transcriptomics, is emerging as a powerful complementary tool in the diagnosis of mitochondrial disease patients for whom extensive prior analysis of DNA sequencing has failed to return a genetic diagnosis.

KEYWORDS:

DNA sequencing; RNA sequencing; diagnostics; mitochondrial dysfunction

PMID:
29950319
DOI:
10.1042/EBC20170110
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center